DOV
46
2
CNX
63
2
GOOG
63
-6
HPQ
52
3
NDAQ
44
2
INTC
31
2
UNH
36
-2
IRM
28
2
PPL
35
6
MAT
39
-2
JNJ
26
-3
SWKS
51
6
HPE
46
4
STX
32
-3
NRG
27
2
URI
35
2
DGX
24
2
WDC
36
-2
STT
44
4
SRE
28
2
DOV
46
2
CNX
63
2
GOOG
63
-6
HPQ
52
3
NDAQ
44
2
INTC
31
2
UNH
36
-2
IRM
28
2
PPL
35
6
MAT
39
-2
JNJ
26
-3
SWKS
51
6
HPE
46
4
STX
32
-3
NRG
27
2
URI
35
2
DGX
24
2
WDC
36
-2
STT
44
4
SRE
28
2
Financhill
Back

Nuveen Quality Municipal Income Fund Vs. Viking Therapeutics Industry Stock Comparison

Sell
13

NAD
Nuveen Quality Municipal Income Fund

Last Price:
$11.56
Seasonality Move:
1.05%
Sell
19

VKTX
Viking Therapeutics

Last Price:
$44.50
Seasonality Move:
40.87%
Sell
13
Nuveen Quality Municipal Income Fund (NAD) is a Sell

Is Nuveen Quality Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen Quality Municipal Income Fund [NAD] share price is $11.46. The Score for NAD is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NAD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $41.49. The Score for VKTX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NAD Stock Price Chart

What is Nuveen Quality Municipal Income Fund's stock price today?

  • The Nuveen Quality Municipal Income Fund share price today is $11.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAD is experiencing slight selling pressure.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $41.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 22.11 Sell
Chaikin Money Flow: -652078 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.84 - 12.3) Sell
Bollinger Bands (100): (11.92 - 12.28) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.1 Sell
Relative Strength Index (14 RSI): 32 Sell
Chaikin Money Flow: 6081687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.09 - 53.27) Sell
Bollinger Bands (100): (51.8 - 67.18) Sell

NAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.88 Sell
20-day SMA: 12.08 Sell
50-day SMA: 12.07 Sell
200-day SMA: 11.75 Sell
8-day EMA: 11.8 Sell
20-day EMA: 11.98 Sell
50-day EMA: 12.05 Sell
200-day EMA: 11.81 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.71 Sell
20-day SMA: 49.34 Sell
50-day SMA: 58.17 Sell
200-day SMA: 62 Sell
8-day EMA: 45.01 Sell
20-day EMA: 49.06 Sell
50-day EMA: 54.7 Sell
200-day EMA: 54.48 Sell

Nuveen Quality Municipal Income Fund Earnings Growth & NAD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

Nuveen Quality Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):